Market Research Logo

Global Patient Monitoring Devices Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

Global Patient Monitoring Devices Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

Patient monitoring devices is a kind of devices which monitors patients outside of conventional clinical settings, that helps in reducing healthcare delivery costs and surge access to care. Patient monitoring devices are employed during major & minor surgeries to monitor patient’s physiological behaviour and related complication. Global patient monitoring devices market is anticipated to rise with a CAGR of 6.3% during forecasted period 2016-2023. Driver of the global patient monitoring market is growing prevalence of lifestyle diseases, growing geriatric population to boost the demand for monitoring devices, increase in the acceptance of remote patient monitoring devices. Major challenging factors of the global patient monitoring devices are unbalanced reimbursement setup and high costs of devices. Opportunities in the global patient monitoring devices market are untapped markets in emerging countries and advancement in technology.

The growing prevalence of lifestyle diseases is one of the major driver of the global patient monitoring devices market. According to WHO, lifestyle diseases are responsible for 63% of global deaths. Moreover, Cardiovascular diseases accounts for around 17.7 million deaths annually, followed by cancer with around 8.8 million, respiratory diseases with 39. million and diabetes with around 1.6 million. According to WHO, cardiovascular diseases are the major cause of death worldwide. It is estimated that around 17.7 million people died from cardiovascular diseases in 2015, representing around 31% of all global deaths. However, around 7.4 million were died due to heart disease and around 6.7 million due to stroke.

Based on segmentation, the global patient monitoring device market is segmented into device type and end user. The device type segment is further segmented into neuromonitoring devices, cardiac monitoring devices, hemodynamic monitoring Devices, fetal & neonatal monitoring devices, multiparameter monitoring devices, remote patient monitoring devices, respiratory monitoring devices, temperature monitoring devices and weight monitoring devices. End user segment is further divided into hospitals & clinics, home settings, and ambulatory surgical centres.

Asia-Pacific holds the largest market share in terms of revenue in 2016 of global patient monitoring devices market, due to increasing aging population. In China, population ageing above 65 years is expected to reach 330 million by the end of 2050, from 110 million in 2014. The major players of the global patient monitoring devices are Abbott Laboratories, Roche Diagnostics, Ge Healthcare, Medtronic PLC, Lifewatch AG, Omron Corporation, Honeywell International, Inc. and others.

Please note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.


1. INTRODUCTION
1. EXECUTIVE SUMMARY
2. ESTIMATION METHODOLOGY
MARKET OVERVIEW
1. GLOBAL PATIENT MONITORING DEVICES MARKET: EVOLUTION & TRANSITION
2. MARKET DEFINITION & SCOPE
3. INDUSTRY STRUCTURE
4. TOTAL MARKET ANALYSIS
4.1. TOP 5 FINDINGS
4.2. TOP 5 OPPORTUNITY MARKETS
4.3. TOP 5 COMPANIES
4.4. TOP 3 COMPETITIVE STRATEGIES
5. ESTIMATION ANALYSIS
6. STRATEGIC ANALYSIS
6.1. INVESTMENT VS. ADOPTION MODEL
6.2. 360 DEGREE INDUSTRY ANALYSIS
6.3. PORTERS 5 FORCE MODEL
6.4. SEE-SAW ANALYSIS
6.5. PIPELINE ANALYSIS
6.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
7. COMPETITIVE ANALYSIS
7.1. KEY STRATEGIES & ANALYSIS
7.2. MARKET SHARE ANALYSIS & TOP COMPANY ANALYSIS
8. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
8.1. INVESTMENT OPPORTUNITIES BY REGIONS
8.2. OPPORTUNITIES IN EMERGING APPLICATIONS
8.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
MARKET DETERMINANTS
1. MARKET DRIVERS
1.1. GROWING GERIATRIC POPULATION
1.2. GROWING PREVALENCE OF LIFESTYLE DISEASES
1.3. INCREASE IN THE ACCEPTANCE OF REMOTE PATIENT MONITORING DEVICES
2. MARKET RESTRAINTS
2.1. LACK OF SKILLED PROFESSIONALS IN PATIENT MONITORING DEVICES
2.2. STRINGENT GOVERNMENT REGULATIONS
3. MARKET OPPORTUNITIES
3.1. UNTAPPED MARKETS IN EMERGING COUNTRIES
3.2. ADVANCEMENT IN TECHNOLOGY
4. MARKET CHALLENGES
4.1. UNBALANCED REIMBURSEMENT SETUP
4.2. HIGH COSTS OF Patient monitoring DEVICES
MARKET SEGMENTATION
1. GLOBAL PATIENT MONITORING DEVICES MARKET BY DEVICE
1.1. MARKET DEFINITION AND SCOPE
1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
1.4. OPPORTUNITY MATRIX
1.5. MARKET SEGMENTATION
1.5.1. GLOBAL HEMODYNAMIC MARKET
1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
1.5.1.3. KEY PLAYERS & KEY PRODUCTS
1.5.1.4. KEY CONCLUSIONS
1.5.2. GLOBAL NEURO MARKET
1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
1.5.2.3. KEY PLAYERS & KEY PRODUCTS
1.5.2.4. KEY CONCLUSIONS
1.5.3. GLOBAL CARDIAC MARKET
1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
1.5.3.3. KEY PLAYERS & KEY PRODUCTS
1.5.3.4. KEY CONCLUSIONS
1.5.4. GLOBAL FETAL AND NEONATAL MARKET
1.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
1.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
1.5.4.3. KEY PLAYERS & KEY PRODUCTS
1.5.4.4. KEY CONCLUSIONS
1.5.5. GLOBAL RESPIRATORY MONITORS MARKET
1.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
1.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
1.5.5.3. KEY PLAYERS & KEY PRODUCTS
1.5.5.4. KEY CONCLUSIONS
1.5.6. GLOBAL REMOTE PATIENT MARKET
1.5.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
1.5.6.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
1.5.6.3. KEY PLAYERS & KEY PRODUCTS
1.5.6.4. KEY CONCLUSIONS
1.5.7. GLOBAL WEIGHT MARKET
1.5.7.1. ADOPTION SCENARIO & MARKET DETERMINANTS
1.5.7.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
1.5.7.3. KEY PLAYERS & KEY PRODUCTS
1.5.7.4. KEY CONCLUSIONS
1.5.8. GLOBAL TEMPERATURE MARKET
1.5.8.1. ADOPTION SCENARIO & MARKET DETERMINANTS
1.5.8.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
1.5.8.3. KEY PLAYERS & KEY PRODUCTS
1.5.8.4. KEY CONCLUSIONS
2. GLOBAL PATIENT MONITORING DEVICES MARKET BY END USERS
2.1. MARKET DEFINITION AND SCOPE
2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
2.4. OPPORTUNITY MATRIX
2.5. MARKET SEGMENTATION
2.5.1. GLOBAL HOSPITALS AND CLINICS MARKET
2.5.1.1. APPLICATION
2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
2.5.1.4. KEY PLAYERS & KEY PRODUCTS
2.5.1.5. KEY CONCLUSIONS
2.5.2. GLOBAL HOME SETTINGS MARKET
2.5.2.1. APPLICATION
2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
2.5.2.4. KEY PLAYERS & KEY PRODUCTS
2.5.2.5. KEY CONCLUSIONS
2.5.3. GLOBAL AMBULATORY SURGICAL CENTERS (ASC) MARKET
2.5.3.1. APPLICATION
2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
2.5.3.4. KEY PLAYERS & KEY PRODUCTS
2.5.3.5. KEY CONCLUSIONS
COMPETITIVE LANDSCAPE
1. KEY STRATEGIES
1.1. LIST OF MERGER & ACQUISITION
1.2. LIST OF JOINT VENTURE
1.3. LIST OF PRODUCT LAUNCHES
1.4. LIST OF PARTNERSHIP
2. TOP 10 COMPANY ANALYSIS
GEOGRAPHICAL ANALYSIS
1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
3. OPPORTUNITY MATRIX
4. GLOBAL PATIENT MONITORING DEVICES MARKET BY REGION 2014-2023 ($ MILLION)
4.1. NORTH AMERICA
4.1.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
4.1.2. TOP COUNTRY ANALYSIS
4.1.2.1. U.S.
4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
4.1.2.1.3. KEY CONCLUSIONS
4.1.2.2. CANADA
4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
4.1.2.2.3. KEY CONCLUSIONS
4.2. EUROPE
4.2.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
4.2.2. TOP COUNTRY ANALYSIS
4.2.2.1. UK
4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
4.2.2.1.3. KEY CONCLUSIONS
4.2.2.2. FRANCE
4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
4.2.2.2.3. KEY CONCLUSIONS
4.2.2.3. GERMANY
4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
4.2.2.3.3. KEY CONCLUSIONS
4.2.2.4. RUSSIA
4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
4.2.2.4.3. KEY CONCLUSIONS
4.2.2.5. REST OF EUROPE
4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
4.2.2.5.3. KEY CONCLUSIONS
4.3. ASIA PACIFIC
4.3.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
4.3.2. TOP COUNTRY ANALYSIS
4.3.2.1. CHINA
4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
4.3.2.1.3. KEY CONCLUSIONS
4.3.2.2. INDIA
4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
4.3.2.2.3. KEY CONCLUSIONS
4.3.2.3. JAPAN
4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
4.3.2.3.3. KEY CONCLUSIONS
4.3.2.4. AUSTRALIA
4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
4.3.2.4.3. KEY CONCLUSIONS
4.3.2.5. REST OF ASIA PACIFIC
4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
4.3.2.5.3. KEY CONCLUSIONS
4.4. ROW
4.4.1. INDUSTRY ANALYSIS 2014-2023 ($ MILLION)
4.4.2. TOP COUNTRY ANALYSIS
4.4.2.1. LATIN AMERICA
4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
4.4.2.1.3. KEY CONCLUSIONS
4.4.2.2. MIDDLE EAST & AFRICA
4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
4.4.2.2.3. KEY CONCLUSIONS
COMPANY PROFILES
1. ABBOTT LABORATORIES(U.S)
1.1. OVERVIEW
1.2. PRODUCT PORTFOLIO
1.3. STRATEGIC INITIATIVES
1.4. SCOT ANALYSIS
1.5. STRATEGIC ANALYSIS
2. BIOTRONIK SE & CO. KG(Germany)
2.1. OVERVIEW
2.2. PRODUCT PORTFOLIO
2.3. STRATEGIC INITIATIVES
2.4. SCOT ANALYSIS
2.5. STRATEGIC ANALYSIS
3. CARDIONET INC.(U.S)
3.1. OVERVIEW
3.2. PRODUCT PORTFOLIO
3.3. STRATEGIC INITIATIVES
3.4. SCOT ANALYSIS
3.5. STRATEGIC ANALYSIS
4. CONMED CORPORATION. (U.S)
4.1. OVERVIEW
4.2. PRODUCT PORTFOLIO
4.3. STRATEGIC INITIATIVES
4.4. SCOT ANALYSIS
4.5. STRATEGIC ANALYSIS
5. F. HOFFMANN-LA ROCHE LTD. (Switzerland)
5.1. OVERVIEW
5.2. PRODUCT PORTFOLIO
5.3. STRATEGIC INITIATIVES
5.4. SCOT ANALYSIS
5.5. STRATEGIC ANALYSIS
6. GENERAL ELECTRIC COMPANY (U.S)
6.1. OVERVIEW
6.2. PRODUCT PORTFOLIO
6.3. STRATEGIC INITIATIVES
6.4. SCOT ANALYSIS
6.5. STRATEGIC ANALYSIS
7. GETINGE AB(Sweden)
7.1. OVERVIEW
7.2. PRODUCT PORTFOLIO
7.3. STRATEGIC INITIATIVES
7.4. SCOT ANALYSIS
7.5. STRATEGIC ANALYSIS
8. HONEYWELL INTERNATIONAL INC. (U.S)
8.1. OVERVIEW
8.2. PRODUCT PORTFOLIO
8.3. STRATEGIC INITIATIVES
8.4. SCOT ANALYSIS
8.5. STRATEGIC ANALYSIS
9. JOHNSON AND JOHNSON (U.S)
9.1. OVERVIEW
9.2. PRODUCT PORTFOLIO
9.3. STRATEGIC INITIATIVES
9.4. SCOT ANALYSIS
9.5. STRATEGIC ANALYSIS
10. KONINKLIJKE PHILIPS N.V. (Netherlands)
10.1. OVERVIEW
10.2. PRODUCT PORTFOLIO
10.3. STRATEGIC INITIATIVES
10.4. SCOT ANALYSIS
10.5. STRATEGIC ANALYSIS
11. LIFEWATCH AG (Switzerland)
11.1. OVERVIEW
11.2. PRODUCT PORTFOLIO
11.3. STRATEGIC INITIATIVES
11.4. SCOT ANALYSIS
11.5. STRATEGIC ANALYSIS
12. MEDTRONIC PLC (U.S)
12.1. OVERVIEW
12.2. PRODUCT PORTFOLIO
12.3. STRATEGIC INITIATIVES
12.4. SCOT ANALYSIS
12.5. STRATEGIC ANALYSIS
13. NIHON KOHDEN CORPORATION (Japan)
13.1. OVERVIEW
13.2. PRODUCT PORTFOLIO
13.3. STRATEGIC INITIATIVES
13.4. SCOT ANALYSIS
13.5. STRATEGIC ANALYSIS
14. OMRON CORPORATION (Japan)
14.1. OVERVIEW
14.2. PRODUCT PORTFOLIO
14.3. STRATEGIC INITIATIVES
14.4. SCOT ANALYSIS
14.5. STRATEGIC ANALYSIS
15. ROCHE DIAGNOSTICS (Switzerland)
15.1. OVERVIEW
15.2. PRODUCT PORTFOLIO
15.3. STRATEGIC INITIATIVES
15.4. SCOT ANALYSIS
15.5. STRATEGIC ANALYSIS
LIST OF TABLES
GLOBAL PATIENT MONITORING DEVICES MARKET BY DEVICE 2014-2023 ($ MILLION)
GLOBAL HEMODYNAMIC MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL NEURO BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL CARDIAC MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL FETAL AND NEONATAL MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL RESPIRATORY MONITORS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL MULTI PARAMETER MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL REMOTE PATIENT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL WEIGHT MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL TEMPERATURE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL PATIENT MONITORING DEVICES MARKET BY END USERS 2014-2023 ($ MILLION)
GLOBAL HOSPITALS AND CLINICS BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL HOME SETTINGS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
GLOBAL AMBULATORY SURGICAL CENTERS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
NORTH AMERICA PATIENT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
EUROPE PATIENT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
ASIA PACIFIC PATIENT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
REST OF THE WORLD PATIENT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
LIST OF FIGURES
GLOBAL HEMODYNAMIC MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
GLOBAL NEUROMONITORING DEVICES MARKET 2014-2023 ($ MILLION)
GLOBAL CARDIAC MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
GLOBAL FETAL AND NEONATAL MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
GLOBAL RESPIRATORY MONITORS MARKET 2014-2023 ($ MILLION)
GLOBAL MULTIPARAMETER MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
GLOBAL REMOTE PATIENT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
GLOBAL WEIGHT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
GLOBAL TEMPERATURE MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
UNITED STATES (U.S.) PATIENT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
CANADA PATIENT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
UNITED KINGDOM (UK) PATIENT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
FRANCE PATIENT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
GERMANY PATIENT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
RUSSIA PATIENT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
ROE PATIENT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
INDIA PATIENT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
CHINA PATIENT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
JAPAN PATIENT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
AUSTRALIA PATIENT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
ROAPAC PATIENT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
LATIN AMERICA PATIENT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)
MENA PATIENT MONITORING DEVICES MARKET 2014-2023 ($ MILLION)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report